113P A phase I study of an anti-IDO1 inhibitor (LY3381916)...

Annals of Oncology 2019 / 12 Vol. 30; Iss. Supplement

113P A phase I study of an anti-IDO1 inhibitor (LY3381916) as monotherapy and in combination with an anti-PD-L1 antibody (LY3300054) in patients with advanced cancer

Kotecki, N, O'Neil, B, Jalal, S, Massard, C, Wallin, J, Szpurka, A, Wang, D, Galvao, V Regnier, Xia, M S, Crowe, K, Geeganage, S, Doman, T, Gandhi, L, Xu, X, Bendell, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz451.021
Date:
December, 2019
File:
PDF, 92 KB
2019
Conversion to is in progress
Conversion to is failed